CLBT
Cellebrite DI
11.30$
+3.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 9.4% | 34.1% | 14.6% | 7.6% | 31.4% | 32.9% | 35.5% | |
| 2.4% | 3.0% | 2.9% | 3.4% | 3.1% | 2.6% | 2.5% | |
| 7.4% | 3.7% | 2.6% | 5.1% | 5.8% | 7.6% | 9.4% | |
| 6.5% | 2.6% | -25.6% | -39.4% | – | – | – | |
| 1.6% | 25.5% | 8.4% | -1.0% | 11.8% | 10.5% | 8.8% | |
| 3.6% | 3.2% | 3.3% | 3.4% | 2.4% | 2.6% | 2.8% | |
| -27.2% | -3.3% | 18.4% | -33.7% | -6.9% | -37.3% | -56.4% | |
| 14.5% | 5.1% | 40.6% | 0.0% | 0.0% | – | – | |
| -0.5% | 0.0% | 0.0% | 0.0% | – | 0.0% | – | |
| 44.0% | -4.4% | -27.8% | 5.2% | 6.7% | 5.1% | 6.2% | |
| 26.1% | 26.8% | 4.9% | -21.6% | 31.3% | 0.5% | -14.1% | |
| 5.8% | 31.0% | 11.3% | 4.2% | 29.0% | 30.3% | 32.7% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.